Future Perspectives

Angela Dispenzieri; Giampaolo Merlini

doi:10.1016/j.hoc.2020.08.009

Future Perspectives

Angela Dispenzieri, Giampaolo Merlini

Hematology

Research output: Contribution to journal › Review article › peer-review

Abstract

Opportunities and challenges in the field of systemic amyloidosis can be grouped into 4 categories. First, a deeper understanding of the pathogenesis of the disease is required. Second, a greater awareness of the disease, which will lead to an earlier diagnosis, is imperative. Third, end points for interventional trials are required to convey us to our fourth aspirations, which are novel therapies for patients with light chain amyloidosis.

Original language	English (US)
Pages (from-to)	1205-1214
Number of pages	10
Journal	Hematology/Oncology Clinics of North America
Volume	34
Issue number	6
DOIs	https://doi.org/10.1016/j.hoc.2020.08.009
State	Published - Dec 2020

Keywords

Early diagnosis
Outcome measures
Pathogenesis
Systemic amyloidosis
Trial design

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.hoc.2020.08.009

Cite this

@article{5d728d8455dd4061a80cc1e5c15d417e,

title = "Future Perspectives",

abstract = "Opportunities and challenges in the field of systemic amyloidosis can be grouped into 4 categories. First, a deeper understanding of the pathogenesis of the disease is required. Second, a greater awareness of the disease, which will lead to an earlier diagnosis, is imperative. Third, end points for interventional trials are required to convey us to our fourth aspirations, which are novel therapies for patients with light chain amyloidosis.",

keywords = "Early diagnosis, Outcome measures, Pathogenesis, Systemic amyloidosis, Trial design",

author = "Angela Dispenzieri and Giampaolo Merlini",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = dec,

doi = "10.1016/j.hoc.2020.08.009",

language = "English (US)",

volume = "34",

pages = "1205--1214",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Future Perspectives

AU - Dispenzieri, Angela

AU - Merlini, Giampaolo

PY - 2020/12

Y1 - 2020/12

N2 - Opportunities and challenges in the field of systemic amyloidosis can be grouped into 4 categories. First, a deeper understanding of the pathogenesis of the disease is required. Second, a greater awareness of the disease, which will lead to an earlier diagnosis, is imperative. Third, end points for interventional trials are required to convey us to our fourth aspirations, which are novel therapies for patients with light chain amyloidosis.

AB - Opportunities and challenges in the field of systemic amyloidosis can be grouped into 4 categories. First, a deeper understanding of the pathogenesis of the disease is required. Second, a greater awareness of the disease, which will lead to an earlier diagnosis, is imperative. Third, end points for interventional trials are required to convey us to our fourth aspirations, which are novel therapies for patients with light chain amyloidosis.

KW - Early diagnosis

KW - Outcome measures

KW - Pathogenesis

KW - Systemic amyloidosis

KW - Trial design

UR - http://www.scopus.com/inward/record.url?scp=85093693543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85093693543&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2020.08.009

DO - 10.1016/j.hoc.2020.08.009

M3 - Review article

C2 - 33099434

AN - SCOPUS:85093693543

SN - 0889-8588

VL - 34

SP - 1205

EP - 1214

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 6

ER -

Future Perspectives

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this